Angiographic and early in-hospital profile of primary percutaneous coronary intervention in patients with substance use disorder presenting with ST-segment elevation myocardial infarction
Résumé
Acute myocardial infarction is increasingly recognized in younger adults, but the angiographic and early clinical profile of ST-segment elevation myocardial infarction among patients with substance use disorder remains incompletely defined. This single-center prospective observational cohort study evaluated the angiographic and early in-hospital profile after primary percutaneous coronary intervention in patients with and without substance use disorder. A total of 175 patients formed the final analytic cohort, including 75 patients with substance use disorder confirmed by DSM-5 criteria supported by point-of-care urine toxicology screening and 100 patients without substance use disorder. Patients with substance use disorder were younger, exclusively male, and had fewer traditional cardiometabolic co-morbidities. In unadjusted analyses, they more often had single-vessel coronary disease and more frequent glycoprotein IIb/IIIa inhibitor use, whereas angiographic thrombus presence was similarly frequent in both groups. After multivariable adjustment, the associations with single-vessel disease and glycoprotein IIb/IIIa inhibitor use were not statistically robust. Patients with substance use disorder presented with a distinct baseline and procedural profile, but adjusted analyses did not support an independent association with the principal angiographic or procedural outcomes assessed, supporting careful toxicology assessment and thrombus-focused procedural planning while avoiding causal interpretation.
Citer ce document
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueStatistiques
Consultations : 1
Téléchargements : 0